Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting
Firstwordpharma News
-
May 8, 2019
Dermatology
Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting
Firstwordpharma News
-
May 8, 2019
Dermatology
Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data...
Biospace News
-
March 19, 2019
0
Dermatology
Bermekimab Resolves Pruritus Rapidly, Effectively Treats Moderate-to-Severe Refractory Atopic Dermatitis: Presented...
Firstwordpharma News
-
March 8, 2019
0
Dermatology
Hyperhidrosis Associated With Anxiety, Depression, and ADD: Presented at AAD
Firstwordpharma News
-
March 8, 2019
0
Dermatology
Platelet-Rich Plasma Effective Therapy for Preventing Hair Loss: Presented at AAD
Firstwordpharma News
-
March 8, 2019
0
Dermatology
Galderma Presented Final Results from Phase 2b Study of Nemolizumab in...
Biospace News
-
March 8, 2019
0
1
2
3
Page 1 of 3
- Advertisement -
LATEST NEWS
Scottish Medicines Consortium daratumumab (Darzalex)
Firstwordpharma News
-
May 13, 2019
0
Amerigen Announces U.S. FDA Approval For Generic Penicillamine 250 mg Capsules
May 8, 2019
Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference
May 14, 2019
MUST READ
Transgene to start clinical development of lead myvac individualized immunotherapy, TG4050, in 2019, under...
Firstwordpharma News
-
March 5, 2019
0
Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGF?1 Activation...
Firstwordpharma News
-
April 2, 2019
0
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Biospace News
-
July 10, 2019
0
Load more
